Jpmorgan Chase & CO Bio Techne Corp Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Bio Techne Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 525,100 shares of TECH stock, worth $27.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
525,100
Previous 756,184 30.56%
Holding current value
$27.6 Million
Previous $60.4 Million 37.41%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$66.37 - $78.17 $15.3 Million - $18.1 Million
-231,084 Reduced 30.56%
525,100 $37.8 Million
Q3 2024

Dec 26, 2024
SELL
$70.96 - $82.35 $10.7 Million - $12.4 Million
-150,782 Reduced 16.62%
756,184 $60.4 Million
Q3 2024

Nov 08, 2024
SELL
$70.96 - $82.35 $10.7 Million - $12.4 Million
-150,782 Reduced 16.62%
756,184 $60.4 Million
Q2 2024

Dec 26, 2024
BUY
$62.12 - $84.15 $9.37 Million - $12.7 Million
150,782 Added 19.94%
906,966 $65 Million
Q2 2024

Aug 12, 2024
BUY
$62.12 - $84.15 $11.5 Million - $15.6 Million
185,206 Added 25.66%
906,966 $65 Million
Q1 2024

Dec 26, 2024
SELL
$65.98 - $77.09 $2.27 Million - $2.65 Million
-34,424 Reduced 4.55%
721,760 $50.8 Million
Q1 2024

May 10, 2024
BUY
$65.98 - $77.09 $10.5 Million - $12.2 Million
158,899 Added 28.23%
721,760 $50.8 Million
Q4 2023

Dec 26, 2024
SELL
$52.83 - $78.22 $10.2 Million - $15.1 Million
-193,323 Reduced 25.57%
562,861 $43.4 Million
Q4 2023

Feb 12, 2024
SELL
$52.83 - $78.22 $2.03 Million - $3 Million
-38,346 Reduced 6.38%
562,861 $43.4 Million
Q3 2023

Nov 14, 2023
SELL
$67.52 - $89.42 $3.14 Million - $4.16 Million
-46,495 Reduced 7.18%
601,207 $40.9 Million
Q2 2023

Aug 11, 2023
BUY
$73.76 - $85.98 $6.4 Million - $7.46 Million
86,717 Added 15.46%
647,702 $52.9 Million
Q1 2023

May 18, 2023
BUY
$71.62 - $86.62 $5.3 Million - $6.41 Million
74,019 Added 15.2%
560,985 $41.6 Million
Q1 2023

May 11, 2023
SELL
$71.62 - $86.62 $2.37 Million - $2.87 Million
-33,117 Reduced 6.37%
486,966 $36.1 Million
Q4 2022

Feb 13, 2023
BUY
$80.67 - $352.29 $30.3 Million - $132 Million
375,416 Added 259.5%
520,083 $43.1 Million
Q3 2022

Nov 14, 2022
SELL
$282.54 - $391.85 $1.88 Million - $2.61 Million
-6,661 Reduced 4.4%
144,667 $41.1 Million
Q2 2022

Aug 11, 2022
SELL
$322.67 - $449.65 $393,980 - $549,022
-1,221 Reduced 0.8%
151,328 $52.5 Million
Q1 2022

May 11, 2022
SELL
$353.85 - $487.79 $3.02 Million - $4.17 Million
-8,542 Reduced 5.3%
152,549 $66.1 Million
Q4 2021

Feb 10, 2022
SELL
$456.15 - $525.06 $25.6 Million - $29.5 Million
-56,093 Reduced 25.83%
161,091 $83.3 Million
Q3 2021

Nov 12, 2021
BUY
$444.87 - $538.88 $96.6 Million - $117 Million
217,184 New
217,184 $105 Million

Others Institutions Holding TECH

# of Institutions
615
Shares Held
155M
Call Options Held
161K
Put Options Held
12.7K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.06B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email